Financials
- Market Capitalization 392.37 M
- Employee 75
- Founded 2021
- CEO N/A
- Website www.upstreambio.com
- Headquarter Delaware, United States
- FIGI BBG017Y2X923
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-10.21
Relación precio/flujo de caja
512.3
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2867 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.23 USD | -2.01% | -14.39% | +7.46% | -40.00% | 553.84 M USD | ||
| 3029 | CBIO Crescent Biopharma, Inc. - Common Stock | 15.72 USD | +0.19% | -5.47% | -11.83% | +22.81% | 433.43 M USD | ||
| 3151 | QTTB Q32 Bio Inc. - Common Stock | 22.11 USD | +3.41% | +66.87% | +73.00% | +989.16% | 374.91 M USD | ||
| 3338 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.59 USD | -0.75% | -3.82% | -4.64% | -6.23% | 305.94 M USD |